ERBB3 and non-small cell lung carcinoma: According to the presence of exosomal proteins, four proteins (CD171, flotillin-1, HER3, and GRP78) were found to be potential markers to predict superior survival of NSCLC patients; nevertheless, CD171 was the most likely biomarker for the prediction.